EDMONTON, AB - In a groundbreaking development for women's health featured on Global News Calgary by journalist Jayme Doll on March 12, 2025, the ENDOSURE test emerges as a beacon of hope for millions suffering from undiagnosed endometriosis in. This non-invasive diagnostic tool promises to deliver results with unprecedented speed and accuracy, slashing the current 5.3-year average diagnostic delay in Canada to less than an hour. Jayme Doll’s reporting for Global News is available at: https://globalnews.ca/news/11074941/lets-talk-about-it-period/
Endometriosis, a condition affecting approximately 1 in 10 women, has long been challenging to diagnose, often requiring invasive procedures and prolonged wait times. The ENDOSURE test, however, offers a paradigm shift in endometriosis detection with accurate, rapid, objective results obtained non-invasively.
Despite its potential, the ENDOSURE test remains largely inaccessible to patients, pending recognition and adoption by the healthcare system.
"It's just existential dread," shares Rose Plican, a 19-year-old endometriosis patient. "Wrapped in a blanket, waiting and wishing away the pain. I just physically can't get out of bed. I can't move. So, it's stopped me in a lot of ways from sort of just living." Rose's story echoes the struggles of countless women facing years-long waitlists for specialists and invasive diagnostic procedures.
Her mother, Carolyn Plican, a patient advocate, emphasizes the psychological impact of a diagnosis: "Suddenly when you're diagnosed, you know it's not in your head. It gives you permission to find better strategies to manage pain and get on a wait list for a laparoscopy to have it excised if it's affecting you really badly."
Dr. Mary Ellen Haggerty supports the ENDOSURE test, stating, "It's a decision help. I think it's really good to make those sorts of diagnosis early. This confirms the diagnosis without being an invasive procedure."
The ball is now in the court of healthcare decision-makers. Will they recognize the value of using the ENDOSURE test for early diagnosis, which has been authorized for sale by Health Canada since 2021, as a significant step towards helping women in debilitating pain? As the medical community debates the role of this new technology, advocates like Carolyn Plican continue to advocate for better access to the ENDOSURE test with its potential to revolutionize endometriosis care by:
- Reducing diagnostic delays
- Minimizing invasive procedures
- Improving patient quality of life
- Potentially lowering healthcare costs long-term
If you are advocating for yourself or someone you love to access earlier diagnostic testing for endometriosis because of pelvic pain, period pain, or infertility, please join the ENDOSURE waitlist at EndoDiagnosis.
For more information about the ENDOSURE test please contact:
Carolyn Plican
1-833-439-3636
EndoDiagnosis, Inc
EndoDiagnosis, Inc was spearheaded by a Canadian team of healthcare professions to bring rapid diagnostic tools and other adjuncts that expedite endometriosis care. The ENDOSURE Test is a non-invasive, 99% accurate diagnostic test for endometriosis, providing instant results in 30-minutes. ENDOSURE provides clinical evidence for practitioners who suspect endometriosis in their patients with dysmenorrhea and/or chronic pelvic pain, infertility & miscarriage or for pre pregnancy screening
EndoDiagnosis, Inc became the Manufacturer's Agent for ENDOSURE in Canada in December 2024. ENDOSURE has been authorized for sale by Health Canada since 2021 for the indication of endometriosis.
Media Contact
Company Name: EndoDiagnosis, Inc
Contact Person: Carolyn Plican
Email: Send Email
Phone: 780-292-4198, 833-439-3636
Country: Canada
Website: https://endodiagnosis.com/
